Background: Vitiligo is a complex autoimmune skin condition characterized by the death of melanocytes, the principle pigment producing cells in the skin. Transcriptome analysis of vitiligo skin revealed significantly reduced levels of proteolipid 1 (PLP1) gene, which is known to be expressed by Schwann cells, as well as significantly up-regulation of genes that are associated with natural killer (NK) cell activity. Hypothesis and Objectives: Schwann cells may be adversely affected in vitiligo and NK cells may potentially play a role in the overall disease pathogenesis. Therefore, the purpose of this study is to characterize the down-regulation of PLP1 and assess the presence of NK cell infiltration in vitiligo skin biopsies. Materials and M...
Epidermal melanocyte loss in vitiligo, triggered by stresses ranging from trauma to emotional stress...
Vitiligo is a chronic multifactorial depigmentation disorder characterized by the destruction and fu...
Vitiligo affects 1% of the worldwide population. Halting disease progression and repigmenting the le...
Background: Vitiligo is a complex autoimmune skin condition characterized by the death of melanocyte...
Vitiligo is characterized by the death of melanocytes in the skin. This is associated with the prese...
Background: Vitiligo is characterized by the death of melanocytes in the skin. This is associated wi...
BACKGROUND: Vitiligo is characterized by the death of melanocytes in the skin. This is associated wi...
<p>Skin biopsies taken from 12 vitiligo patients and 6 normal individuals were subjected to immunofl...
Vitiligo is an acquired immune-mediated disorder of pigmentation clinically characterized by well-de...
Background: Vitiligo is a common pigmentary disorder. Studies on its pathogenesis extensively invest...
<p>Natural killer (NK) cells from 6 pairs of vitiligo skin explants (lesional and non-lesional) and ...
Vitiligo is a chronic multifactorial depigmentation disorder characterized by the destruction and fu...
Accumulating studies have indicated immune-based destruction of melanocytes in both segmental vitili...
Vitiligo is an autoimmune skin disease characterized by the destruction of melanocytes by autoreacti...
Vitiligo is an autoimmune skin disease characterized by the destruction of melanocytes by autoreacti...
Epidermal melanocyte loss in vitiligo, triggered by stresses ranging from trauma to emotional stress...
Vitiligo is a chronic multifactorial depigmentation disorder characterized by the destruction and fu...
Vitiligo affects 1% of the worldwide population. Halting disease progression and repigmenting the le...
Background: Vitiligo is a complex autoimmune skin condition characterized by the death of melanocyte...
Vitiligo is characterized by the death of melanocytes in the skin. This is associated with the prese...
Background: Vitiligo is characterized by the death of melanocytes in the skin. This is associated wi...
BACKGROUND: Vitiligo is characterized by the death of melanocytes in the skin. This is associated wi...
<p>Skin biopsies taken from 12 vitiligo patients and 6 normal individuals were subjected to immunofl...
Vitiligo is an acquired immune-mediated disorder of pigmentation clinically characterized by well-de...
Background: Vitiligo is a common pigmentary disorder. Studies on its pathogenesis extensively invest...
<p>Natural killer (NK) cells from 6 pairs of vitiligo skin explants (lesional and non-lesional) and ...
Vitiligo is a chronic multifactorial depigmentation disorder characterized by the destruction and fu...
Accumulating studies have indicated immune-based destruction of melanocytes in both segmental vitili...
Vitiligo is an autoimmune skin disease characterized by the destruction of melanocytes by autoreacti...
Vitiligo is an autoimmune skin disease characterized by the destruction of melanocytes by autoreacti...
Epidermal melanocyte loss in vitiligo, triggered by stresses ranging from trauma to emotional stress...
Vitiligo is a chronic multifactorial depigmentation disorder characterized by the destruction and fu...
Vitiligo affects 1% of the worldwide population. Halting disease progression and repigmenting the le...